63 related articles for article (PubMed ID: 28159675)
1. CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis.
Leguit RJ; Broekhuizen R; de Witte M; Raymakers RAP; Goldschmeding R
Virchows Arch; 2024 May; 484(5):837-845. PubMed ID: 38602559
[TBL] [Abstract][Full Text] [Related]
2. The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the
Verachi P; Gobbo F; Martelli F; Martinelli A; Sarli G; Dunbar A; Levine RL; Hoffman R; Massucci MT; Brandolini L; Giorgio C; Allegretti M; Migliaccio AR
Front Oncol; 2022; 12():853484. PubMed ID: 35392239
[TBL] [Abstract][Full Text] [Related]
3. Identity of Gli1
Sena IFG; Prazeres PHDM; Santos GSP; Borges IT; Azevedo PO; Andreotti JP; Almeida VM; Paiva AE; Guerra DAP; Lousado L; Souto L; Mintz A; Birbrair A
Exp Hematol; 2017 Oct; 54():12-16. PubMed ID: 28690072
[TBL] [Abstract][Full Text] [Related]
4. A challenging case of mast cell sarcoma primarily involving the bone marrow.
Abi-Saab T; Matkovic E
Blood; 2024 Apr; 143(16):1676. PubMed ID: 38635256
[No Abstract] [Full Text] [Related]
5. Retraction: Mast cells induce ductular reaction mimicking liver injury in mice through mast cell-derived transforming growth factor beta 1 signaling.
Hepatology; 2024 Feb; ():. PubMed ID: 38377369
[No Abstract] [Full Text] [Related]
6. The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis.
Xu Y; Lan P; Wang T
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004032
[TBL] [Abstract][Full Text] [Related]
7. Functionally Relevant Cytokine/Receptor Axes in Myelofibrosis.
Pozzi G; Carubbi C; Cerreto GM; Scacchi C; Cortellazzi S; Vitale M; Masselli E
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760903
[TBL] [Abstract][Full Text] [Related]
8. Immune cell populations differ in patients undergoing revision total knee arthroplasty for arthrofibrosis.
Limberg AK; Salib CG; Tibbo ME; Vargas-Hernandez JS; Bettencourt JW; Bayram B; Berry CE; Dudakovic A; Bolon B; van Wijnen AJ; Morrey ME; Sanchez-Sotelo J; Berry DJ; Carter JM; Abdel MP
Sci Rep; 2022 Dec; 12(1):22627. PubMed ID: 36587032
[TBL] [Abstract][Full Text] [Related]
9. Two to tango! IL-13 and TGF-β drive myelofibrosis.
Jutzi JS; Mullally A
Blood; 2022 Dec; 140(26):2767-2768. PubMed ID: 36580345
[No Abstract] [Full Text] [Related]
10. IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms.
Melo-Cardenas J; Bezavada L; Crawford JC; Gurbuxani S; Cotton A; Kang G; Gossett J; Marinaccio C; Weinberg R; Hoffman R; Migliaccio AR; Zheng Y; Derecka M; Rinaldi CR; Crispino JD
Blood; 2022 Dec; 140(26):2805-2817. PubMed ID: 36283106
[TBL] [Abstract][Full Text] [Related]
11. Overview of First-Line and Second-Line Pharmacotherapies for Osteoarthritis with Special Focus on Intra-Articular Treatment.
Nowaczyk A; Szwedowski D; Dallo I; Nowaczyk J
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163488
[TBL] [Abstract][Full Text] [Related]
12. Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis.
Seidel H; Hertfelder HJ; Oldenburg J; Kruppenbacher JP; Afrin LB; Molderings GJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445665
[TBL] [Abstract][Full Text] [Related]
13. Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes.
Karagianni A; Ravid K
Blood; 2022 May; 139(21):3127-3137. PubMed ID: 34428274
[TBL] [Abstract][Full Text] [Related]
14. Differential mast cell numbers and characteristics in human tuberculosis pulmonary lesions.
Garcia-Rodriguez KM; Bini EI; Gamboa-Domínguez A; Espitia-Pinzón CI; Huerta-Yepez S; Bulfone-Paus S; Hernández-Pando R
Sci Rep; 2021 May; 11(1):10687. PubMed ID: 34021178
[TBL] [Abstract][Full Text] [Related]
15. Cytokines frequently implicated in myeloproliferative neoplasms.
Wang Y; Zuo X
Cytokine X; 2019 Mar; 1(1):100005. PubMed ID: 33604548
[TBL] [Abstract][Full Text] [Related]
16. Increased number of pulmonary megakaryocytes in COVID-19 patients with diffuse alveolar damage: an autopsy study with clinical correlation and review of the literature.
Valdivia-Mazeyra MF; Salas C; Nieves-Alonso JM; Martín-Fragueiro L; Bárcena C; Muñoz-Hernández P; Villar-Zarra K; Martín-López J; Ramasco-Rueda F; Fraga J; Jiménez-Heffernan JA
Virchows Arch; 2021 Mar; 478(3):487-496. PubMed ID: 32915265
[TBL] [Abstract][Full Text] [Related]
17. Soluble transforming growth factor beta-1 enhances murine mast cell release of Interleukin 6 in IgE-independent and Interleukin 13 in IgE-dependent settings in vitro.
Lyons DO; Plewes MR; Pullen NA
PLoS One; 2018; 13(11):e0207704. PubMed ID: 30444930
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow fibrosis at diagnosis predicts survival for primary acute myeloid leukemia.
Wu Z; Chen R; Wu L; Zou L; Ding F; Wang M; Liu X
Clin Transl Oncol; 2017 Dec; 19(12):1462-1468. PubMed ID: 28589431
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
